Research Insights on Aging Brains
As our bodies age, so do our brains, which tend to produce fewer new neurons over time. Recently, researchers have uncovered a significant process that could potentially slow this age-related decline in neuron production.
In older age, neural stem cells (NSCs) that typically develop into neurons become less active—almost like they’re winding down after many years of function. This decline correlates with cognitive deterioration.
A key factor in the waning activity of NSCs is the gradual deterioration of telomeres, the protective caps at the ends of DNA strands. Every time a cell divides, these telomeres wear down a bit more, which eventually hampers the cells’ growth and division abilities, leading to an increase in cell death.
A study from the National University of Singapore (NUS) aimed to delve deeper into these mechanisms to see if there was a way to rejuvenate these tired NSCs. “The decline in neural stem cell regeneration has been closely associated with neurological aging,” explains chemical biologist Derrick Sek Tong Ong from NUS.
He adds, “Insufficient neural stem cell regeneration hinders the creation of new cells essential for learning and memory.” While previous research suggested that some aspects of defective NSC regeneration could be improved, the fundamental processes behind it are still not very clear.
Using a combination of human NSC analysis and mouse model studies, the researchers identified a protein named cyclin D-binding myb-like transcription factor 1 (DMTF1). This transcription factor can bind to DNA, influencing the activation or deactivation of genes.
Though DMTF1 isn’t a new discovery, its specific influence on NSCs is. The researchers found that DMTF1 levels are higher in younger, healthier brains, and increasing the presence of DMTF1 in the cells promoted growth and division among NSCs—possibly renewing the neuron production typical of a younger brain.
Interestingly, shorter telomeres seemed to lower DMTF1 levels, but artificially enhancing DMTF1 in cells did not change the telomere length—indicating that the protein might have found a way around this limitation.
Particularly, DMTF1 activates two ‘helper’ genes, Arid2 and Ss18, which stimulate cell growth by turning on additional genes that reestablish the biological processes for neuron creation.
The implications of understanding this mechanism at such a granular level suggest we may eventually be able to control it, perhaps through treatments that promote neuron growth despite advancing age.
“Our findings indicate that DMTF1 can aid in the multiplication of neural stem cells as the brain ages,” mentions neuroscientist Liang Yajing from NUS. It’s a crucial breakthrough, but we need to temper our expectations: this study was conducted in lab conditions with mouse models, so any claims about enhancing neuron production remain unproven.
Now that the mechanism is identified, future research can expand on this work. There’s potential for manipulating DMTF1 to reverse some aging effects on the brain, although that’s still under exploration.
Next, researchers will likely need to conduct more detailed investigations on how DMTF1 could possibly restore NSC activity and whether it can improve learning and memory. Caution is essential here; excessive cell growth could lead to issues like cancer.
This study adds to a growing list of research examining brain aging and how we might slow, halt, or even reverse some effects of aging.
While factors like diet and exercise seem to contribute positively, the quest for therapies to rejuvenate aging brain cells continues to be a tantalizing but distant goal.
Ultimately, an aging brain is more prone to cognitive issues and diseases, including dementia. Although this research doesn’t directly address those concerns, it may help enhance our understanding of typical brain aging.
“Comprehending the mechanisms behind neural stem cell regeneration strengthens the groundwork for investigating age-related cognitive decline,” concludes Ong.
The research findings are published in Science Advances.
